Seeking Broad Intervention In India, Eli Lilly Goes To Roots To Check Non-communicable Diseases

MUMBAI - Following the Indian government's heightened concerns over a sharply increased prevalence rate of non-communicable diseases such as diabetes and cancer, Eli Lilly & Co. has allocated $8-9 million to analyze the disease burden in India and devise intervention strategies based on the data